Literature DB >> 12784381

Results from controlled clinical trials: how relevant for clinical practice?

Tore K Kvien, Knut Mikkelsen, Bjørn-Yngvar Nordvåg.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12784381

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.

Authors:  M S Heiberg; C Kaufmann; E Rødevand; K Mikkelsen; W Koldingsnes; P Mowinckel; T K Kvien
Journal:  Ann Rheum Dis       Date:  2007-01-09       Impact factor: 19.103

2.  National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference.

Authors:  Ladan Afifi; Lindsey Shankle; April W Armstrong; Marc Boas; Alisha Bridges; Vivian Chiguil; Frank Doris; Kristina Callis Duffin; Eric Fielding; Roy Fleischmann; Joel M Gelfand; Matthew Kiselica; Catherine Kiselica; Brian LaFoy; John J Latella; Junko Takeshita; Sarah Truman; Marilyn T Wan; Vickie Wilkerson; Jashin J Wu; Michael P Siegel; Wilson Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2017

3.  Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.

Authors:  G Haugeberg; B Griffiths; K B Sokoll; P Emery
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 4.  Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?

Authors:  T Pincus; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

5.  Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort.

Authors:  Jeffrey D Greenberg; Mitsumasa Kishimoto; Vibeke Strand; Stanley B Cohen; Thomas P Olenginski; Thomas Harrington; Shelly P Kafka; George Reed; Joel M Kremer
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.